Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:0
作者
Haşim Boyacı
Hale Maral
Gupse Turan
İlknur Başyiğit
Meltem Ö. Dillioğlugil
Füsun Yıldız
Melih Tugay
Ayşe Pala
Cengiz Erçin
机构
[1] Kocaeli University School of Medicine,Department of Chest Diseases
[2] Kocaeli University School of Medicine,Department of Biochemistry
[3] Kocaeli University School of Medicine,Department of Pathology
[4] Kocaeli University School of Medicine,Department of Pediatric Surgery
[5] Kocaeli TIP Fakültesi,undefined
来源
Molecular and Cellular Biochemistry | 2006年 / 281卷
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
暂无
中图分类号
学科分类号
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague–Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin + erdosteine (BLM + ERD), and saline alone (control). The BLM and BLM + ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM + ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM + ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 ± 0.15, 0.11 ± 0.02, and 0.087± 0.03 nmol/mg protein in BLM, BLM + ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 ± 0.06, 0.60 ± 0.09, and 0.56± 0.1 μmol/mg protein in BLM, BLM + ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 ± 12.4, 253.2± 25.2, and 287.9± 34.4 nmol/mg protein) (SOD levels were 1.42± 0.12, 1.75± 0.17, and 1.89± 0.09 U/mg protein) in BLM, BLM + ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:8
相关论文
共 50 条
[41]   Carnosol attenuates bleomycin-induced lung damage via suppressing fibrosis, oxidative stress and inflammation in rats [J].
Kalantar, Hadi ;
Sadeghi, Elahe ;
Abolnezhadian, Farhad ;
Goudarzi, Mehdi ;
Hemmati, Ali Asghar ;
Basir, Zahra ;
Kalantar, Mojtaba .
LIFE SCIENCES, 2021, 287
[42]   Antifibrosis effects of Shenge Yangfei Capsules on bleomycin-induced pulmonary fibrosis in rats [J].
Jia, Hui ;
Wang, Zuo-jun ;
Wu, Qiong ;
Xu, Zi-ru ;
Zhang, Jing-yi ;
Ma, Hong-da ;
Zhao, Qing-chun .
CHINESE HERBAL MEDICINES, 2018, 10 (04) :411-415
[43]   Carvacrol protects rats against bleomycin-induced lung oxidative stress, inflammation, and fibrosis [J].
Pashmforosh, Marzieh ;
Vardanjani, Hossein Rajabi ;
Khorsandi, Layasadat ;
Shariati, Saeedeh ;
Mohtadi, Shokooh ;
Khodayar, Mohammad Javad .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (12) :10075-10089
[44]   Resveratrol alleviates bleomycin-induced lung injury in rats [J].
Sener, Goksel ;
Topaloglu, Nurhayat ;
Sehirli, A. Ozer ;
Ercan, Feriha ;
Gedik, Nursal .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (06) :642-649
[45]   Curcumin protects bleomycin-induced lung injury in rats [J].
Venkatesan, N ;
Punithavathi, V ;
Chandrakasan, G .
LIFE SCIENCES, 1997, 61 (06) :PL51-PL58
[46]   Halofuginone does not reduce fibrosis in bleomycin-induced lung injury [J].
Tzurel, A ;
Segel, MJ ;
Or, R ;
Goldstein, RH ;
Breuer, R .
LIFE SCIENCES, 2002, 71 (14) :1599-1606
[47]   rhCygb benefits bleomycin-induced established pulmonary fibrosis in rats [J].
Li, Zhen ;
Lin, Zhongshun ;
Wang, Ping ;
Dong, Wenqi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (07) :2141-2152
[48]   Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats [J].
Gao, Lili ;
Tang, Haiying ;
He, Huanyu ;
Liu, Jia ;
Mao, Jingwei ;
Ji, Hong ;
Lin, Hongli ;
Wu, Taihua .
FRONTIERS IN PHARMACOLOGY, 2015, 6
[49]   Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats [J].
Hilal Ermis ;
Hakan Parlakpinar ;
Gazi Gulbas ;
Nigar Vardi ;
Alaadin Polat ;
Asli Cetin ;
Talat Kilic ;
Zeynep Ayfer Aytemur .
Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 :1103-1110
[50]   Inhibition of bleomycin-induced pulmonary fibrosis by extract from Rosmarinus officinalis in rats [J].
Yang, Liteng ;
Liu, Xin ;
Cheng, Deyun ;
Fang, Xun ;
Mu, Mao ;
Hu, Xiaobo ;
Nie, Li .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03) :6054-6061